Diabetes Care:低血糖症增加心血管事件风险

2013-04-11 Diabetes Care 丁香园

低血糖症是1型或2型糖尿病患者降糖治疗的一个主要的副作用。糖尿病患者治疗过程中低血糖症与严重的健康结局相关,然而,有低血糖发作史的2型糖尿病门诊患者,其临床结局大部分是未知的。为了探讨在2型糖尿病患者,临床症状性低血糖症与心血管事件和总死亡率的关系,来自中国台湾国立卫生研究院,人口健康科学研究所的Shao-Yuan Chuang教授及其团队进行了一项研究(Association of clinic

低血糖症是1型或2型糖尿病患者降糖治疗的一个主要的副作用。糖尿病患者治疗过程中低血糖症与严重的健康结局相关,然而,有低血糖发作史的2型糖尿病门诊患者,其临床结局大部分是未知的。为了探讨在2型糖尿病患者,临床症状性低血糖症与心血管事件和总死亡率的关系,来自中国台湾国立卫生研究院,人口健康科学研究所的Shao-Yuan Chuang教授及其团队进行了一项研究(Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes:a nationwide population-based study),该研究发现症状性低血糖症与心血管事件、全因住院和全因死亡风险增加有关。该研究结果发表在2013年4月的美国《糖尿病治疗》(Diabetes Care)杂志上,该杂志的影响因子为8.087。
该研究是一项前瞻性研究,研究人群来源于1998至2009年期间台湾国立卫生研究院公布的国民健康保险研究数据库,包含77611例新诊断的2型糖尿病患者。该研究包含随机选择低血糖的2型糖尿病患者和与之对照的无低血糖的2型糖尿病患者。研究低血糖症与全因死亡率和心血管事件的关系,包括中风、冠心病、心血管疾病和全因住院。
该研究结果表明,在77611例患者(500例住院患者,1344例门诊患者)中共发生1844例低血糖事件。轻度(门诊患者)和重度(住院患者)低血糖的病例出现合并症的比例较高(合并症包括高血压、肾脏疾病、癌症、卒中和心脏疾病)。在多元Cox回归模型中,校正糖尿病治疗因素后,有低血糖的糖尿病患者在临床治疗期间的心血管事件发生风险显著增高。校正倾向评分构建模型后,轻度和重度低血糖患者心血管疾病(HR 2.09 [95%CI 1.63-2.67])、全因住院(2.51 [2.00-3.16])和总死亡率(2.48 [1.41-4.38])的风险比(HR)仍然较高。
该研究发现,症状性低血糖,不论轻度和重度,与心血管事件、全因住院和全因死亡风险增加有关。低血糖发作的糖尿病患者可能需要更多的关注。
糖尿病相关的拓展阅读:


Association of Clinical Symptomatic Hypoglycemia With Cardiovascular Events and Total Mortality in Type 2 Diabetes: A nationwide population-based study.
OBJECTIVE
Hypoglycemia is associated with serious health outcomes for patients treated for diabetes. However, the outcome of outpatients with type 2 diabetes who have experienced hypoglycemia episodes is largely unknown.
RESEARCH DESIGN AND METHODS
The study population, derived from the National Health Insurance Research Database released by the Taiwan National Health Research Institutes during 1998-2009, comprised 77,611 patients with newly diagnosed type 2 diabetes. We designed a prospective study consisting of randomly selected hypoglycemic type 2 diabetic patients and matched type 2 diabetic patients without hypoglycemia. We investigated the relationships of hypoglycemia with total mortality and cardiovascular events, including stroke, coronary heart disease, cardiovascular diseases, and all-cause hospitalization.
RESULTS
There were 1,844 hypoglycemic events (500 inpatients and 1,344 outpatients) among the 77,611 patients. Both mild (outpatient) and severe (inpatient) hypoglycemia cases had a higher percentage of comorbidities, including hypertension, renal diseases, cancer, stroke, and heart disease. In multivariate Cox regression models, including diabetes treatment adjustment, diabetic patients with hypoglycemia had a significantly higher risk of cardiovascular events during clinical treatment periods. After constructing a model adjusted with propensity scores, mild and severe hypoglycemia still demonstrated higher hazard ratios (HRs) for cardiovascular diseases (HR 2.09 [95% CI 1.63-2.67]), all-cause hospitalization (2.51 [2.00-3.16]), and total mortality (2.48 [1.41-4.38]).
CONCLUSIONS
Symptomatic hypoglycemia, whether clinically mild or severe, is associated with an increased risk of cardiovascular events, all-cause hospitalization, and all-cause mortality. More attention may be needed for diabetic patients with hypoglycemic episodes.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1759255, encodeId=8ee71e592552b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 25 21:37:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901062, encodeId=115e1901062bf, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Nov 09 06:37:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636638, encodeId=ea1e1636638e6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Feb 19 07:37:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643304, encodeId=e4ab1643304c3, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Wed Mar 05 19:37:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287598, encodeId=33d0128e598d4, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457789, encodeId=6324145e7899d, content=<a href='/topic/show?id=b63926366a2' target=_blank style='color:#2F92EE;'>#低血糖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26366, encryptionId=b63926366a2, topicName=低血糖症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b0b5986082, createdName=appleandpeer, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1759255, encodeId=8ee71e592552b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 25 21:37:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901062, encodeId=115e1901062bf, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Nov 09 06:37:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636638, encodeId=ea1e1636638e6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Feb 19 07:37:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643304, encodeId=e4ab1643304c3, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Wed Mar 05 19:37:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287598, encodeId=33d0128e598d4, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457789, encodeId=6324145e7899d, content=<a href='/topic/show?id=b63926366a2' target=_blank style='color:#2F92EE;'>#低血糖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26366, encryptionId=b63926366a2, topicName=低血糖症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b0b5986082, createdName=appleandpeer, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1759255, encodeId=8ee71e592552b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 25 21:37:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901062, encodeId=115e1901062bf, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Nov 09 06:37:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636638, encodeId=ea1e1636638e6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Feb 19 07:37:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643304, encodeId=e4ab1643304c3, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Wed Mar 05 19:37:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287598, encodeId=33d0128e598d4, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457789, encodeId=6324145e7899d, content=<a href='/topic/show?id=b63926366a2' target=_blank style='color:#2F92EE;'>#低血糖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26366, encryptionId=b63926366a2, topicName=低血糖症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b0b5986082, createdName=appleandpeer, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1759255, encodeId=8ee71e592552b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 25 21:37:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901062, encodeId=115e1901062bf, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Nov 09 06:37:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636638, encodeId=ea1e1636638e6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Feb 19 07:37:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643304, encodeId=e4ab1643304c3, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Wed Mar 05 19:37:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287598, encodeId=33d0128e598d4, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457789, encodeId=6324145e7899d, content=<a href='/topic/show?id=b63926366a2' target=_blank style='color:#2F92EE;'>#低血糖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26366, encryptionId=b63926366a2, topicName=低血糖症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b0b5986082, createdName=appleandpeer, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1759255, encodeId=8ee71e592552b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 25 21:37:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901062, encodeId=115e1901062bf, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Nov 09 06:37:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636638, encodeId=ea1e1636638e6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Feb 19 07:37:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643304, encodeId=e4ab1643304c3, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Wed Mar 05 19:37:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287598, encodeId=33d0128e598d4, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457789, encodeId=6324145e7899d, content=<a href='/topic/show?id=b63926366a2' target=_blank style='color:#2F92EE;'>#低血糖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26366, encryptionId=b63926366a2, topicName=低血糖症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b0b5986082, createdName=appleandpeer, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1759255, encodeId=8ee71e592552b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 25 21:37:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901062, encodeId=115e1901062bf, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Nov 09 06:37:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636638, encodeId=ea1e1636638e6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Feb 19 07:37:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643304, encodeId=e4ab1643304c3, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Wed Mar 05 19:37:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287598, encodeId=33d0128e598d4, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457789, encodeId=6324145e7899d, content=<a href='/topic/show?id=b63926366a2' target=_blank style='color:#2F92EE;'>#低血糖症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26366, encryptionId=b63926366a2, topicName=低血糖症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b0b5986082, createdName=appleandpeer, createdTime=Sat Apr 13 00:37:00 CST 2013, time=2013-04-13, status=1, ipAttribution=)]

相关资讯

AIM:含豆类的低血糖指数饮食降低心血管危险

  加拿大学者进行的研究表明, 2型糖尿病患者将豆类作为低血糖指数(GI)饮食,既能改善血糖控制,也能降低心血管危险。文章发表于10月22日出版的《内科学文献》(Arch Intern Med)杂志。   研究者将121例2型糖尿病患者随机分为2组,一组给予低GI豆类饮食(鼓励患者增加豆类摄入每天至少1杯),另一组给予全麦纤维饮食,共3个月。   结果显示,低GI

NEJM:人工胰腺降低院外患者夜间低血糖

人工胰腺降低院外患者夜间低血糖    以色列国家儿童糖尿病研究中心Phillip等人进行的一项研究发现,与传感器增强型胰岛素泵治疗相比,人工胰腺体系治疗院外糖尿病患者可减少夜间低血糖症,且血糖控制得到改善。该研究结果在线发表于新一期的《新英格兰杂志》[N Engl J Med. 2013 Feb 28;368(9):824-3

Diabetes Care:LOGIC-Insulin算法指导强化血糖控制效果佳

  来自荷兰鲁汶大学的一项前瞻性、平行组、随机对照临床试验显示,应用计算机软件程序LOGIC-Insulin实施强化血糖控制(TGC)的效能优于经验丰富的护士,且不增加低血糖事件的发生率。该研究2013年2月在线发表在《糖尿病护理》杂志(Diabetes care)上。   对危重患者实施TGC较为困难,且工作强度大,导致血糖控制效果不佳和低血糖发生率增加。LOGIC-Insul

Diabetes Care: 低血糖和空腹血糖受损均可预测心血管疾病发病风险

不同空腹血糖水平下的心血管疾病HRs 尽管糖尿病增加心血管疾病发病风险和死亡率,但是低于糖尿病诊断标准的空腹血糖水平与心血管事件间的量效关系尚未十分明确。针对这种情况,来自韩国Severance医院国家健康护理中心的Park博士等人进行了一项研究,研究发现,低血糖和空腹血糖受损均可作为中风和冠状动脉心脏病的预测因子,并且,与最低心血管疾病发病风险相关的空腹血糖水平范围较窄。研究结果在线发表于

J Diabetes:糖尿病治疗模式变革即将到来?

■ 控制血糖并非唯一目标,药物选择应权衡风险与获益   治疗模式变革,SU及其替代疗法作用或需重新评估   自退伍军人糖尿病研究(VADT)、控制糖尿病患者心血管风险行动研究(ACCORD)和糖尿病治疗与心血管保护行动:培哚普利/吲达帕胺复方制剂与格列齐特缓释片对照评估研究(ADVANCE)结果发表3~4年后,更多研究者认识到,针对所有糖尿病人群制定单一的血糖控制目标可能不妥,这大

BMC Endocr Disord:强化降糖发生低血糖的预测因素

  德国研究者进行的一项前瞻性研究(BMC Endocr Disord. 2012 Oct 17;12(1):23)表明,低血糖是接受强化降糖治疗的2型糖尿病门诊患者的常见并发症。既往发生过低血糖、微血管疾病(如视网膜病变)和接受胰岛素治疗的患者,尤其需要注意预防低血糖发生。服用噻唑烷二酮类药物、DPP-4抑制剂与GLP-1类似物的患者发生低血糖的